Huazhuo Jiedu Prescription Treats Ulcerative Colitis by Inhibiting Excessive Mitophagy via PINK1/Parkin Signaling Pathway
|更新时间:2025-05-07
|
Huazhuo Jiedu Prescription Treats Ulcerative Colitis by Inhibiting Excessive Mitophagy via PINK1/Parkin Signaling Pathway
增强出版
“The latest research has found that Huazhuo Jiedu Formula improves intestinal mucosal damage and mitochondrial structure in mice with ulcerative colitis by regulating the PINK1/Parkin pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 11, Pages: 182-189(2025)
ZHANG Haofeng,ZHOU Jinye,LIU Ziwei,et al.Huazhuo Jiedu Prescription Treats Ulcerative Colitis by Inhibiting Excessive Mitophagy via PINK1/Parkin Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):182-189.
Effect of Dima Decoction on BNIP3 Protein and mRNA Expressions inIntestinal Epithelial Cells of Ulcerative Colitis Mice
Nano Oral Colon Targeted Drug Delivery System in Treatment of Ulcerative Colitis: A Review
Comparison of Pharmacokinetics and Tissue Distribution of Free Anthraquinones and Gallic Acid in Mice with Ulcerative Colitis Before and After Processing of Rhei Radix et Rhizoma Carbonisata
Mechanisms of Zhuyuwan in Treating both Intrahepatic Cholestasis and Ulcerative Colitis Based on Homotherapy for Heteropathy
Related Author
ZHANG Haofeng
ZHI Zheng
YANG Qian
LI Bolin
LI Yi-fang
WANG Rui
ZHA An-sheng
WANG Li-na
Related Institution
Hebei Provincial Hospital of Traditional Chinese Medicine
Anhui University of Chinese Medicine
First Affiliated Hospital of Anhui University of Chinese Medicine
Jiangxi University of Chinese Medicine
College of Food Science and Technology,Nanchang University